新規免疫チェックポイント阻害薬ヒト型抗ヒトPD-1抗体ニボルマブ(オプジーボ®点滴静注20 mg,100 mg)の薬理学的特性および臨床効果

Overview of attention for article published in Folia Pharmacologica Japonica, August 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#4 of 789)
High Attention Score compared to outputs of the same age (90th percentile)

Mentioned by

blogs: 1 blog
twitter: 3 X users

patent: 7 patents

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 7 Mendeley

Summary Blogs X Patents Dimensions citations

So far, Dimensions has found 1 citation of this research output.

1

The most recent citing publication is shown below. View this citation on Dimensions.

Immunotherapy versus standard chemotherapy for treatment of extensive-stage small-cell lung cancer: a systematic review

Article in Immunotherapy (June 2021)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.